Dermata Therapeutics, Inc. (DRMA)
0.8699
+0.01
(+1.16%)
USD |
NASDAQ |
Oct 20, 16:00
0.85
-0.02
(-2.29%)
After-Hours: 05:45
Dermata Therapeutics Market Cap : 3.499M for Oct. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 20, 2026 | 3.499M |
| October 19, 2026 | 3.459M |
| October 16, 2026 | 3.459M |
| October 15, 2026 | 3.660M |
| October 14, 2026 | 2.668M |
| October 13, 2026 | 3.459M |
| October 12, 2026 | 3.578M |
| October 09, 2026 | 4.102M |
| October 08, 2026 | 4.304M |
| October 07, 2026 | 4.505M |
| October 06, 2026 | 4.545M |
| October 05, 2026 | 4.464M |
| October 02, 2026 | 4.444M |
| October 01, 2026 | 4.464M |
| September 30, 2026 | 4.424M |
| September 29, 2026 | 4.545M |
| September 28, 2026 | 4.505M |
| September 25, 2026 | 4.585M |
| September 24, 2026 | 4.706M |
| September 23, 2026 | 4.505M |
| September 22, 2026 | 4.625M |
| September 21, 2026 | 4.625M |
| September 18, 2026 | 4.666M |
| September 17, 2026 | 4.666M |
| September 16, 2026 | 4.625M |
| Date | Value |
|---|---|
| September 15, 2026 | 4.545M |
| September 14, 2026 | 4.625M |
| September 11, 2026 | 4.786M |
| September 10, 2026 | 4.826M |
| September 09, 2026 | 4.867M |
| September 08, 2026 | 5.028M |
| September 04, 2026 | 4.867M |
| September 03, 2026 | 4.947M |
| September 02, 2026 | 5.148M |
| September 01, 2026 | 5.229M |
| August 31, 2026 | 5.188M |
| August 28, 2026 | 5.390M |
| August 27, 2026 | 5.872M |
| August 26, 2026 | 6.476M |
| August 25, 2026 | 6.918M |
| August 24, 2026 | 6.556M |
| August 21, 2026 | 5.711M |
| August 20, 2026 | 5.550M |
| August 19, 2026 | 5.912M |
| August 18, 2026 | 5.752M |
| August 17, 2026 | 5.872M |
| August 14, 2026 | 5.872M |
| August 13, 2026 | 6.315M |
| August 12, 2026 | 5.550M |
| August 11, 2026 | 4.344M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 273.55M |
| Perspective Therapeutics, Inc. | 262.40M |
| MiMedx Group, Inc. | 616.41M |
| ABVC BioPharma, Inc. | 23.96M |
| Agilent Technologies, Inc. | 48.78B |
Market Cap Related Metrics
| Price to Book Value | 1.003 |
| Price | 0.8699 |
| Earnings Yield | -504.2% |